期刊文献+

磷酸化组蛋白H3在肿瘤中的研究进展 被引量:2

Progress of phosphohistone H3 in tumors
原文传递
导出
摘要 磷酸化组蛋白H3(PHH3)是新近发现的五个核心组蛋白之一,在真核细胞中与其他组蛋白构成染色质中的主要蛋白组分。PHH3在有丝分裂的G2期及M期达到最大值,因此被认为是一种特异性的核分裂标志物。目前PHH3已经被证实对确定肿瘤细胞的核分裂象,区分核分裂象和凋亡小体、核碎片非常有用。文章就PHH3在肿瘤中的研究现状进行综述。 Phosphohistone H3(PHH3)is one of the five newly discovered nucleocardial histones.PHH3 with other histones constitute the main protein components in chromatin in eukaryotic.For it reached the maximum value in G2 phase and M phase with mitosis,so it was considered as a specific nuclear fission marker.At present,PHH3 has been proved to be very useful to determine the nuclear fission images of tumor cells,and to distinguish the nuclear fission images from apoptotic bodies and nuclear fragments.This paper reviews the research status of PHH3 in tumors.
作者 李小红 付蓉 张雨涛 Li Xiaohong;Fu Rong;Zhang Yutao(Department of Pathology,Zigong First People's Hospital,Zigong 643000,China)
出处 《肿瘤研究与临床》 CAS 2019年第1期66-68,共3页 Cancer Research and Clinic
关键词 肿瘤 磷酸化组蛋白H3 有丝分裂 Neoplasms Phosphohistone H3 Mitosis
  • 相关文献

参考文献2

二级参考文献15

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics[ J ]. CA Cancer J Clin, 2011,61 (2) :69-90.
  • 2Fredholm H, Eaker S, Frisell J, et al. Breast cancer in young women : poor survival despite intensive treatment [ J ]. PloS One, 2009,11(4) : e7695.
  • 3Ribalta T, Mccutcheon I E, Aldape K I), et al. The mitosis-spe- cific antibody anti-phospho- histone-H3 ( PHH3 ) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria [J]. Am J Surg Pathol, 2004,28(11) :1532 -6.
  • 4Santisteban M, Reynolds C, Barr Fritcher E G, et al. Ki-67: a time-varying biomarker of risk of breast cancer in atypical hyper- plasia[J]. Breast cancer Res Treat, 2010,121 (2) :431 - 7.
  • 5Shin Y, Hyeno J, Lee B, et al. PHH3 as an Ancillary mitotic marker in gastrointestinal stromal tumors [ J ]. J Pathol Transl Med, 2015,49(1) :23-9.
  • 6Schimming T T, Grabellus F, Roner M, et al. Phh3 immunostain- ing improve interobserver agreement of mitotic index in thin mela- nomas[J]. Am J Dermatopathol, 2012,34 (3) :266 - 9.
  • 7Alkhasawneh A, Reith J D, Toro T Z, et al. Interobserver varia- bility of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors [ J]. Am J Clin Pathol, 2015,143 (3) :385 -92.
  • 8Brunner A, Riss P, Helnze G, et al. PHH3 and survivin are co- expressed in high-risk endometfial cancer and are prognostic rele- vant[J]. Br J Cancer, 2012,107(1) :84 -90.
  • 9Lee L I-I, Yang H, Bigras G. Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases[J]. Sci Rep, 2014,4:5122.
  • 10Hightower E, Cabanillas M E, Fuller G N, et al. Phospho-histone H3 ( pHH3 ) immuno-reactivity as a prognostic marker in non-func- tioning pituitary adenomas[ J]. Pituitary, 2012,15(4) :556 -61.

共引文献13

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部